PGNX
Fisher Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-105,125
| Closed | -$399K | – | 869 |
|
|
2020
Q1 | $399K | Hold |
105,125
| – | – | ﹤0.01% | 647 |
|
|
2019
Q4 | $535K | Hold |
105,125
| – | – | ﹤0.01% | 652 |
|
|
2019
Q3 | $531K | Hold |
105,125
| – | – | ﹤0.01% | 679 |
|
|
2019
Q2 | $649K | Hold |
105,125
| – | – | ﹤0.01% | 639 |
|
|
2019
Q1 | $488K | Sell |
105,125
-300
| -0.3% | -$1.39K | ﹤0.01% | 646 |
|
|
2018
Q4 | $443K | Buy |
105,425
+300
| +0.3% | +$1.26K | ﹤0.01% | 663 |
|
|
2018
Q3 | $659K | Sell |
105,125
-26,736
| -20% | -$168K | ﹤0.01% | 619 |
|
|
2018
Q2 | $1.06M | Sell |
131,861
-171,831
| -57% | -$1.38M | ﹤0.01% | 580 |
|
|
2018
Q1 | $2.27M | Hold |
303,692
| – | – | ﹤0.01% | 513 |
|
|
2017
Q4 | $1.81M | Buy |
303,692
+51,762
| +21% | +$308K | ﹤0.01% | 529 |
|
|
2017
Q3 | $1.85M | Buy |
251,930
+89,808
| +55% | +$661K | ﹤0.01% | 513 |
|
|
2017
Q2 | $1.1M | Buy |
162,122
+64,490
| +66% | +$438K | ﹤0.01% | 529 |
|
|
2017
Q1 | $922K | Buy |
97,632
+18,604
| +24% | +$176K | ﹤0.01% | 512 |
|
|
2016
Q4 | $683K | Sell |
79,028
-28,635
| -27% | -$247K | ﹤0.01% | 535 |
|
|
2016
Q3 | $682K | Sell |
107,663
-32,698
| -23% | -$207K | ﹤0.01% | 540 |
|
|
2016
Q2 | $754K | Buy |
140,361
+170
| +0.1% | +$913 | ﹤0.01% | 531 |
|
|
2016
Q1 | $683K | Hold |
140,191
| – | – | ﹤0.01% | 543 |
|
|
2015
Q4 | $859K | Buy |
140,191
+56,941
| +68% | +$349K | ﹤0.01% | 525 |
|
|
2015
Q3 | $476K | Buy |
+83,250
| New | +$476K | ﹤0.01% | 553 |
|